(Q40458352)

20 September 2017

title

Clinical Significance of Monitoring Plasma Levels of Psychotropic Drugs (English)

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

10 June 2022

author name string

P. L. Morselli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A261680

10 June 2022

E. Zarifian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A261680

10 June 2022

language of work or name

English

0 references

publication date

1 January 1979

1 reference

full work available at URL

20 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F9780470720578.ch8

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

https://onlinelibrary.wiley.com/doi/full/10.1002/9780470720578.ch8

10 June 2022

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

Ciba Foundation Symposium

10 June 2022

published in

1 reference

20 September 2017

issue

74

1 reference

20 September 2017

page(s)

115-139

1 reference

Influence of route of administration on haloperidol plasma levels in psychotic patients

20 September 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

Plasma Level Monitoring of Antipsychotic Drugs

10 June 2022

5

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

Relation of Plasma Prolactin to Clinical Response in Schizophrenic Patients

10 June 2022

9

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

Haloperidol Plasma Level Monitoring in Pediatric Patients

10 June 2022

15

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

Effects of mode of management on plasma chlorpromazine in psychiatric patients.

10 June 2022

18

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

Variability of prolactin response to intravenous and intramuscular haloperidol in normal adult men

10 June 2022

20

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration

10 June 2022

21

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

High-Dose Propranolol in Schizophrenia

10 June 2022

23

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

Blood Levels of Neuroleptic Drugs in Nonresponding Chronic Schizophrenic Patients

10 June 2022

25

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

Nortriptyline in depressed patients with high plasma levels. II

10 June 2022

28

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

Indications for Long-Term Pharmacological Treatment of Schizophrenic Syndromes*

10 June 2022

34

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

A guide to the use of psychotropic medication in children and adolescents

10 June 2022

4

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

Individual variability in response to haloperidol

5 February 2023

6

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

Correlation between plasma concentrations of chlorpromazine and clinical response

5 February 2023

19

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

Thymoleptic and neuroleptic drug plasma levels in psychiatry: current status

5 February 2023

29

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

Individual variability in response to haloperidol

5 February 2023

30

1 reference

https://api.crossref.org/works/10.1002/9780470720578.CH8

5 February 2023

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=261680

10 June 2022

1 reference